Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
HCATthis companyHealth Catalyst, Inc.	$1.52	-0.94×	0.68×	0.54×	-2.61×	-854.1%	33.5%	-11.6%	-57.2%	-72.4%	-8.6%	-0.1%	0.7×	-1.09×	-2.2×	1.89×	0.0%	5	-6.58	2	C+
CRBUCaribou Biosciences, Inc.	$0.46	-1×	1.22×	13.31×	-1.13×	-908.6%	67.3%	-1220.5%	-1327.4%	-121.2%	-89.8%	-75.7%	0.22×	-0.1×	0×	5.71×	0.0%	3	-7.25	2	C
ENTAEnanta Pharmaceuticals, Inc.	$11.49	-3.12×	3.95×	3.91×	-5.99×	-669.1%	93.0%	-130.7%	-125.4%	-126.5%	-31.4%	-12.6%	3.11×	-2.38×	-11.11×	4.21×	0.0%	3	-0.92	1	C-
HSDTSolana Company	$1.89	-1.56×	0.21×	10.59×	-1.43×	-610.6%	91.7%	-351.0%	-679.6%	-13.6%	-7.0%	-96.2%	0×	0.18×	-33.26×	10.33×	0.0%	3	1.76	1	C-
OBIOOrchestra BioMed Holdings, Inc.	$5.68	-3.74×	3.13×	5.92×	-3.5×	-202.6%	99.4%	-154.7%	-157.4%	-83.2%	-52.4%	-25.0%	0.25×	0.37×	-45.13×	6.45×	0.0%	3	-2.89	1	D+
OMOutset Medical, Inc.	$4.37	-0.69×	0.44×	0.47×	-1.97×	-1772.3%	39.1%	-55.8%	-68.3%	-64.3%	-29.2%	-83.5%	0.8×	-1.06×	-4.78×	6.67×	0.0%	3	-6.08	2	C
Peer median	—	-1.56×	1.22×	5.92×	-1.97×	-669.1%	91.7%	-154.7%	-157.4%	-83.2%	-31.4%	-75.7%	0.25×	-0.1×	-11.11×	6.45×	0.0%	3	-2.89	1	—